Mycobacteria and the new quinolones.
作者信息
Leysen D C, Haemers A, Pattyn S R
机构信息
Department of Pharmaceutical Sciences, University of Antwerp, Belgium.
出版信息
Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.
Abstract
摘要
相似文献
1
Mycobacteria and the new quinolones.分枝杆菌与新型喹诺酮类药物。
Antimicrob Agents Chemother. 1989 Jan;33(1):1-5. doi: 10.1128/AAC.33.1.1.
2
Sparfloxacin is more bactericidal than ofloxacin against Mycobacterium leprae in mice.在小鼠中，司帕沙星对麻风杆菌的杀菌作用比氧氟沙星更强。
Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):66-9.
3
Activity of sparfloxacin against Mycobacterium leprae measured by the proportional bactericidal test.通过比例杀菌试验测定司帕沙星对麻风分枝杆菌的活性。
Int J Lepr Other Mycobact Dis. 1993 Dec;61(4):605-8.
4
Anti-Mycobacterium leprae activity of several quinolones studied in the mouse.几种喹诺酮类药物在小鼠体内抗麻风分枝杆菌的活性研究。
Int J Lepr Other Mycobact Dis. 1991 Dec;59(4):613-7.
5
In-vitro activities of quinolones against mycobacteria.喹诺酮类药物对分枝杆菌的体外活性
J Antimicrob Chemother. 1993 Dec;32(6):797-808. doi: 10.1093/jac/32.6.797.
6
[Molecular mechanism of the acquisition of new-quinolone resistance in Mycobacterium leprae and M. tuberculosis and rapid differentiation methods for resistant bacilli].[麻风分枝杆菌和结核分枝杆菌对新型喹诺酮耐药性获得的分子机制及耐药菌的快速鉴别方法]
Nihon Hansenbyo Gakkai Zasshi. 2011 Feb;80(1):17-27. doi: 10.5025/hansen.80.17.
7
8
The first joint THELEP-Sasakawa Memorial Health Foundation workshop on experimental chemotherapy of leprosy.首届麻风病实验化疗THELEP-笹川纪念健康基金会联合研讨会。
Int J Lepr Other Mycobact Dis. 1987 Dec;55(4 Suppl):807-13.
9
Antimycobacterial activities of two newer ansamycins, R-76-1 and DL 473.两种新型安莎霉素R-76-1和DL 473的抗分枝杆菌活性
Int J Lepr Other Mycobact Dis. 1986 Dec;54(4):563-77.
10
The mystery of the mycobacterial 'persistor'.
Tuber Lung Dis. 1992 Oct;73(5):249-51. doi: 10.1016/0962-8479(92)90128-7.
引用本文的文献
1
Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis.耐多药和广泛耐药结核病的治疗。
Microbiol Spectr. 2017 Mar;5(2). doi: 10.1128/microbiolspec.TNMI7-0042-2017.
2
In vitro activity of a new isothiazoloquinolone, ACH-702, against Mycobacterium tuberculosis and other mycobacteria.新型异噻唑酮喹诺酮 ACH-702 对结核分枝杆菌和其他分枝杆菌的体外活性。
Antimicrob Agents Chemother. 2010 May;54(5):2188-90. doi: 10.1128/AAC.01603-09. Epub 2010 Mar 15.
3
Clinical significance of Mycobacterium asiaticum isolates in Queensland, Australia.澳大利亚昆士兰州亚洲分枝杆菌分离株的临床意义。
J Clin Microbiol. 2010 Jan;48(1):162-7. doi: 10.1128/JCM.01602-09. Epub 2009 Oct 28.
4
Disposition kinetics and urinary excretion of ciprofloxacin in goats following single intravenous administration.单次静脉注射后山羊体内环丙沙星的处置动力学及尿排泄情况
J Vet Sci. 2008 Sep;9(3):241-5. doi: 10.4142/jvs.2008.9.3.241.
5
In vitro and in vivo activities of novel fluoroquinolones alone and in combination with clarithromycin against clinically isolated Mycobacterium avium complex strains in Japan.新型氟喹诺酮类药物单独及与克拉霉素联合应用对日本临床分离的鸟分枝杆菌复合群菌株的体外和体内活性
Antimicrob Agents Chemother. 2007 Nov;51(11):4071-6. doi: 10.1128/AAC.00410-07. Epub 2007 Aug 20.
6
In vitro activity of ciprofloxacin, ofloxacin and levofloxacin against Mycobacterium tuberculosis.环丙沙星、氧氟沙星和左氧氟沙星对结核分枝杆菌的体外活性。
Ann Saudi Med. 2005 Sep-Oct;25(5):409-12. doi: 10.5144/0256-4947.2005.409.
7
Identification of mycobacterial species by PCR sequencing of quinolone resistance-determining regions of DNA gyrase genes.通过对DNA促旋酶基因喹诺酮耐药决定区进行PCR测序来鉴定分枝杆菌菌种。
J Clin Microbiol. 2003 Mar;41(3):1311-5. doi: 10.1128/JCM.41.3.1311-1315.2003.
8
Clinical role of protein binding of quinolones.喹诺酮类药物蛋白结合的临床作用。
Clin Pharmacokinet. 2002;41(10):741-50. doi: 10.2165/00003088-200241100-00004.
9
The disposition kinetics, urinary excretion and dosage regimen of ciprofloxacin in buffalo calves (Bubalus bubalis).
Vet Res Commun. 2001 Dec;25(8):641-9. doi: 10.1023/a:1012791113342.
10
Infection of the subcutis and skin of cats with rapidly growing mycobacteria: a review of microbiological and clinical findings.猫皮下组织和皮肤感染快速生长的分枝杆菌：微生物学和临床发现综述
J Feline Med Surg. 2000 Mar;2(1):35-48. doi: 10.1053/jfms.2000.0051.
本文引用的文献
1
Treatment of disease due to Mycobacterium intracellulare.胞内分枝杆菌所致疾病的治疗。
Rev Infect Dis. 1981 Sep-Oct;3(5):1052-9. doi: 10.1093/clinids/3.5.1052.
2
In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.乙胺丁醇、异烟肼、卡那霉素、利福平及链霉素对鸟分枝杆菌-胞内分枝杆菌复合体的体外协同活性
Antimicrob Agents Chemother. 1982 Jul;22(1):148-50. doi: 10.1128/AAC.22.1.148.
3
The pharmacokinetics and tissue penetration of ofloxacin.氧氟沙星的药代动力学和组织穿透性。 （注：原文中多了一个of，正确表述应该是The pharmacokinetics and tissue penetration of ofloxacin ）
J Antimicrob Chemother. 1984 Dec;14(6):647-52. doi: 10.1093/jac/14.6.647.
4
In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.新型抗菌物质DL-8280的体外抗分枝杆菌活性——通过DL-8280药敏试验鉴别分枝杆菌某些菌种及相关菌属
Microbiol Immunol. 1983;27(12):1129-32. doi: 10.1111/j.1348-0421.1983.tb02933.x.
5
In vitro activities of norfloxacin and ciprofloxacin against Mycobacterium tuberculosis, M. avium complex, M. chelonei, M. fortuitum, and M. kansasii.诺氟沙星和环丙沙星对结核分枝杆菌、鸟分枝杆菌复合体、龟分枝杆菌、偶然分枝杆菌和堪萨斯分枝杆菌的体外活性。
Antimicrob Agents Chemother. 1984 Jul;26(1):94-6. doi: 10.1128/AAC.26.1.94.
6
Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae.偶然分枝杆菌和龟分枝杆菌五个亚组的抗菌药敏性
Antimicrob Agents Chemother. 1985 Dec;28(6):807-11. doi: 10.1128/AAC.28.6.807.
7
In-vitro activity of some quinoline derivatives against Mycobacterium fortuitum.
J Antimicrob Chemother. 1985 Feb;15(2):254-5. doi: 10.1093/jac/15.2.254.
8
Antituberculosis activity of ofloxacin (DL 8280) on experimental tuberculosis in mice.氧氟沙星（DL 8280）对小鼠实验性结核病的抗结核活性。
Am Rev Respir Dis. 1985 Oct;132(4):915. doi: 10.1164/arrd.1985.132.4.915.
9
In vitro antituberculosis activity of a new antibacterial substance ofloxacin (DL8280).新型抗菌物质氧氟沙星（DL8280）的体外抗结核活性
Am Rev Respir Dis. 1985 Mar;131(3):348-51. doi: 10.1164/arrd.1985.131.3.348.
10
Disseminated infection with Mycobacterium avium-intracellulare. A report of 13 cases and a review of the literature.鸟分枝杆菌-胞内分枝杆菌播散性感染。13例报告及文献复习。
Medicine (Baltimore). 1985 Jan;64(1):36-48. doi: 10.1097/00005792-198501000-00003.
Zotero 插件